In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Convening of an Extraordinary General Meeting ('EGM') of the Company on Tuesday, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gennex Laboratories Ltd's Board of Directors convened on April 16, 2026, and approved convening an Extraordinary General Meeting (EGM) on May 12, 2026 at 12:30 PM via video conferencing. The primary agenda is to regularize the appointment of Ms. Khushbu Kachhawa as a Non-Executive Independent Woman Director. The Board also appointed NSDL as the authorized agency for facilitating the EGM and e-voting, and appointed Ms. Sweety Kapoor as the Scrutinizer. E-voting will be open from May 9 to May 11, 2026, with a cut-off date of May 8, 2026.
This is a routine governance event involving the formal regularization of an existing director's appointment. The stock may see mild positive reaction given the addition of an Independent Woman Director, which strengthens board compliance.